T 1186/19 (Lixisenatide combination therapy/SANOFI) of 15.07.2021
- European Case Law Identifier
- ECLI:EP:BA:2021:T118619.20210715
- Date of decision
- 15 July 2021
- Case number
- T 1186/19
- Online on
- 11 July 2022
- Petition for review of
- -
- Application number
- 12721268.6
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Lixisenatide as add-on therapy to basal insulin in type 2 diabetes
- Applicant name
- Sanofi-Aventis Deutschland GmbH
- Opponent name
- Generics [UK] Ltd
- Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 56
- Keywords
- Inventive step - (yes)
- Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The appeal is dismissed.
2. The patent proprietor's appeal fee is to be reimbursed at 25%.